ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,670,353 | +47.0% | 34,930 | +9.6% | 0.32% | +32.1% |
| Q3 2023 | $1,136,593 | -5.1% | 31,882 | +22.8% | 0.24% | +1.2% |
| Q2 2023 | $1,198,088 | +1042.2% | 25,972 | +1047.2% | 0.24% | +135.3% |
| Q4 2022 | $104,891 | +41.7% | 2,264 | +26.1% | 0.10% | +50.0% |
| Q3 2022 | $74,000 | -57.5% | 1,795 | -38.5% | 0.07% | -48.5% |
| Q2 2022 | $174,000 | +3.0% | 2,918 | +25.5% | 0.13% | +65.0% |
| Q1 2022 | $169,000 | – | 2,326 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |